New Molecular Resistance Mechanisms against Antibiotics in Bacteria

Document Type : Review Article

Authors

1 PhD Candidate, Department of Biology, School of Sciences, University of Isfahan, Isfahan, Iran

2 Associate Professor, Department of Biology, School of Sciences, University of Isfahan, Isfahan, Iran

Abstract

Only a short time after the discovery of antibiotics by Alexander Fleming, antibiotic-resistant bacteria were reported. Besides the traditional mechanisms of resistance in bacteria, new mechanisms have been described by different researchers. For example, recently a new gene operon of D-alanine-D-serine called VanL that cuased resistant to the antibiotic vancomycin was reported. Other researchers have shown that Klebsiella pneumoniae strains lost purine Ompk36 that have a major role in the antibiotic diffusion into cells, are resistant to carbapenem. In 2011, the first full resistance to tigecycline was reported that the enzyme-linked monooxygenase flavin hydroxyl TetX cause deactivation of antibiotics. In 2012, high resistance to mupricin antibiotic was described that intermediated by a new locus named mupB. In addition, in 2013, it was showed that some strains of Enterococcus faecalis can move daptomycin antibiotic from its target to other places and so inhibit its activity. Removal of whole target gene (PBP3) of ceftazidime in Burkholderia pseudomallei was reported in 2012. In other hand, new role of riboswitch for resistance to aminoglycoside antibiotics reported in 2013. In addition, recent studies have indicated a relationship between SOS response and quorum sensing with antibiotic resistance and new antibiotic resistance mechanisms in bacterial biofilm and persister cells are known. In this review, recent studies have been conducted to identify these new mechanisms.

Keywords

References

  1. Bockstael K, Van Aerschot A. Antimicrobial resistance in bacteria. Cent Eur J Med 2009; 4(2): 141-55.
  2. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010; 74(3): 417-33.
  3. Jawetz E, Melnick JL, Adelberg EA. Review of medical microbiology. New York, NY: Springer; 1980. p. 880-1200.
  4. Zinsser H, Joklik WK. Zinsser microbiology. 20th ed. New York, NY; 1988. p. 348-420.
  5. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med 2006; 119(6 Suppl 1): S3-10.
  6. Canton R, Morosini MI. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev 2011; 35(5): 977-91.
  7. Theuretzbacher U. Global antibacterial resistance: The never-ending story. Journal of Global Antimicrobial Resistance1(2): 63-9.
  8. Shokri D, Zaghian S, Khodabakhsh F, Fazeli H, Mobasherizadeh S, Ataei B. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains. J Microbiol Immunol Infect 2014; 47(5): 371-6.
  9. Mobasherizadeh S, Shokri D, Zargarzadeh AH, Jalalpour S, Ebneshahidi SA, Sajadi M. Antimicrobial resistance surveillance among hospitalized and non-hospitalized extend-spectrum beta-lactamase producing Escherichia coli from four tertiary-care hospitals in Isfahan, Iran; 2008-2011. Afric J Microb Res 2012; 6(5): 953-9.
  10. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 2008; 52(7): 2667-72.
  11. Sho T, Muratani T, Hamasuna R, Yakushiji H, Fujimoto N, Matsumoto T. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 beta-lactamase production in Japan. Microb Drug Resist 2013; 19(4): 274-81.
  12. Volkers G, Palm GJ, Weiss MS, Wright GD, Hinrichs W. Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase. FEBS Lett 2011; 585(7): 1061-6.
  13. Seah C, Alexander DC, Louie L, Simor A, Low DE, Longtin J, et al. MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56(4): 1916-20.
  14. Bebrone C, Bogaerts P, Delbruck H, Bennink S, Kupper MB, Rezende de CR, et al. GES-18, a new carbapenem-hydrolyzing GES-Type beta-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob Agents Chemother 2013; 57(1): 396-401.
  15. Ilina EN, Malakhova MV, Bodoev IN, Oparina NY, Filimonova AV, Govorun VM. Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae. Front Microbiol 2013; 4: 186.
  16. Ohneck EA, Zalucki YM, Johnson PJ, Dhulipala V, Golparian D, Unemo M, et al. A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio 2011; 2(5).
  17. Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, et al. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids. MBio 2013; 4(4).
  18. Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother 2012; 56(4): 2184-6.
  19. Cuzon G, Bonnin RA, Nordmann P. First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. PLoS One 2013; 8(4): e61322.
  20. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, et al. FIM-1, a new acquired metallo-beta-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 2013; 57(1): 410-6.
  21. Torok ME, Chantratita N, Peacock SJ. Bacterial gene loss as a mechanism for gain of antimicrobial resistance. Curr Opin Microbiol 2012; 15(5): 583-7.
  22. Jia X, Zhang J, Sun W, He W, Jiang H, Chen D, et al. Riboswitch control of aminoglycoside antibiotic resistance. Cell 2013; 152(1-2): 68-81.
  23. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 2004; 305(5690): 1629-31.
  24. Guerin E, Cambray G, Sanchez-Alberola N, Campoy S, Erill I, Da RS, et al. The SOS response controls integron recombination. Science 2009; 324(5930): 1034.
  25. Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, Plesiat P, et al. Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. PLoS Pathog 2012; 8(6): e1002778.
  26. Kint CI, Verstraeten N, Fauvart M, Michiels J. New-found fundamentals of bacterial persistence. Trends Microbiol 2012; 20(12): 577-85.
  27. Fauvart M, De Groote VN, Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 2011; 60(Pt 6): 699-709.
  28. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. Persisters: a distinct physiological state of E. coli. BMC Microbiol 2006; 6: 53.
  29. Gefen O, Gabay C, Mumcuoglu M, Engel G, Balaban NQ. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A 2008; 105(16): 6145-9.
  30. Wu Y, Vulic M, Keren I, Lewis K. Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother 2012; 56(9): 4922-6.
  31. Shatalin K, Shatalina E, Mironov A, Nudler E. H2S: a universal defense against antibiotics in bacteria. Science 2011; 334(6058): 986-90.
  32. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011; 334(6058): 982-6.
  33. Dorr T, Lewis K, Vulic M. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet 2009; 5(12): e1000760.
  34. Tripathi A, Dewan PC, Barua B, Varadarajan R. Additional role for the ccd operon of F-plasmid as a transmissible persistence factor. Proc Natl Acad Sci U S A 2012; 109(31): 12497-502.
  35. Moker N, Dean CR, Tao J. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 2010; 192(7): 1946-55.
  36. Leung V, Levesque CM. A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol 2012; 194(9): 2265-74.
  37. Vega NM, Allison KR, Khalil AS, Collins JJ. Signaling-mediated bacterial persister formation. Nat Chem Biol 2012; 8(5): 431-3.
  38. Defoirdt T, Boon N, Bossier P. Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog 2010; 6(7): e1000989.
  39. Defoirdt T, Verstraete W, Bossier P. Luminescence, virulence and quorum sensing signal production by pathogenic Vibrio campbellii and Vibrio harveyi isolates. J Appl Microbiol 2008; 104(5): 1480-7.
  40. Koch B, Liljefors T, Persson T, Nielsen J, Kjelleberg S, Givskov M. The LuxR receptor: the sites of interaction with quorum-sensing signals and inhibitors. Microbiology 2005; 151(Pt 11): 3589-602.
  41. Joelsson A, Liu Z, Zhu J. Genetic and phenotypic diversity of quorum-sensing systems in clinical and environmental isolates of Vibrio cholerae. Infect Immun 2006; 74(2): 1141-7.
  42. Hirakawa H, Tomita H. Interference of bacterial cell-to-cell communication: a new concept of antimicrobial chemotherapy breaks antibiotic resistance. Front Microbiol 2013; 4: 114.
  43. LaSarre B, Federle MJ. Exploiting quorum sensing to confuse bacterial pathogens. Microbiol Mol Biol Rev 2013; 77(1): 73-111.
  44. Wilder CN, Allada G, Schuster M. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 2009; 77(12): 5631-9.
  45. Wang L, Zhang C, Gong F, Li H, Xie X, Xia C, et al. Influence of Pseudomonas aeruginosa pvdQ gene on altering antibiotic susceptibility under swarming conditions. Curr Microbiol 2011; 63(4): 377-86.
  46. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35(4): 322-32.
  47. Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother 2011; 55(6): 2655-61.
  48. Bjedov I, Tenaillon O, Gerard B, Souza V, Denamur E, Radman M, et al. Stress-induced mutagenesis in bacteria. Science 2003; 300(5624): 1404-9.
  49. Conibear TC, Collins SL, Webb JS. Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS One 2009; 4(7): e6289.
  50. Romling U, Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 2012; 272(6): 541-61.
  51. Mandsberg LF, Ciofu O, Kirkby N, Christiansen LE, Poulsen HE, Hoiby N. Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother 2009; 53(6): 2483-91.
  52. Mai-Prochnow A, Lucas-Elio P, Egan S, Thomas T, Webb JS, Sanchez-Amat A, et al. Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several gram-negative bacteria. J Bacteriol 2008; 190(15): 5493-501.
  53. Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Hoiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 2008; 7(5): 391-7.
  54. Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Hoiby N, et al. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin Microbiol Infect 2009; 15(1): 60-6.
Journal of Isfahan Medical School
Volume 33, Issue 328 - Serial Number 328
January and February 2015
Pages 410-428

Files

History

  • Receive Date: 25 October 2013
  • Revise Date: 02 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics